The report covers forecast and analysis for the virus filtration market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the virus filtration market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the virus filtration market on a global level.
In order to give the users of this report a comprehensive view of the virus filtration market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses customer and region segments which are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.
The study provides a decisive view of the virus filtration market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.
By product, the global virus filtration market is divided into filtration systems, kits & reagents, services, and others. Among these, the filtration systems segment was the highest revenue grosser in 2017. On the basis of application, the market is segmented into biologicals, vaccines and therapeutics, blood and blood products, stem cell products, medical device, air purification and water purification, tissue and tissue products, and cellular and gene therapy products. The end users in the virus filtration market are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. The pharmaceutical and biotechnological companies dominated the market and accounted for the largest share in 2017.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for virus filtration based on individual segment and applications in all the regions and countries.
Some of the key players in virus filtration market include Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International, Inc., Sartorius AG, Sigma-Aldrich Corporation, Asahi Kasei Medical Co., Ltd., WuXi PharmaTech Inc., and General Electric Company, among others.
This report segments the global virus filtration market as follows:
Global Virus Filtration Market: Product Segment Analysis
- Kits and Reagents
- Filtration Systems
- Other Products
- Services
Global Virus Filtration Market: Application Segment Analysis
- Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
- Medical Device
- Air Purification
- Water Purification
Global Virus Filtration Market: End-user Segment Analysis
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Medical Device Companies
Global Virus Filtration Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
